# CVE-2018-14787: Privilege escalation in IntelliSpace Cardiovascular (ISCV) products

> An attacker with escalated privileges can execute arbitrary code with local administrative permissions by accessing writable executable folders in Philips ISCV products.

- **Severity:** High 7.8 (`CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H`)
- **Exploited in the wild:** Not known
- **Login needed:** Any signed-in user
- **Attackable:** Local or same network only
- **Victim action needed:** Not needed
- **Fix available:** No
- **Published:** 22 Aug 2018
- **Updated:** 16 Sep 2024
- **Also known as:** GHSA-29jf-w9mr-r2xp

## What is CVE-2018-14787?

CVE-2018-14787 is a high-severity vulnerability in Philips IntelliSpace Cardiovascular (ISCV) products, published on 22 Aug 2018. It can only be exploited from the same machine or local network, with no action from the victim.

### Official description

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

Weakness: CWE-269 (Improper Privilege Management)

## Which versions are affected by CVE-2018-14787?

It affects 2 products.


Products: Philips Intellispace Cardiovascular, Philips Xcelera.

## How do I fix CVE-2018-14787?

No fix has been published for CVE-2018-14787 yet. Limit exposure of the affected software until one is available.

## Is CVE-2018-14787 being exploited?

There is no known exploitation of CVE-2018-14787 in the wild and no public exploit code.

## Other vulnerabilities in Philips IntelliSpace Cardiovascular (ISCV) products

- [CVE-2017-14111](https://insights.sbomify.com/CVE-2017-14111/): Information disclosure in n/a (high 7.2)
- [CVE-2018-14789](https://insights.sbomify.com/CVE-2018-14789/): Privilege escalation in IntelliSpace Cardiovascular (ISCV) products (medium 6.7)
- [CVE-2018-5438](https://insights.sbomify.com/CVE-2018-5438/): Auth bypass in n/a (medium 6.3)

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2018-14787 and fix it if it is affected.

What it is: CVE-2018-14787 is a high-severity vulnerability in Philips IntelliSpace Cardiovascular (ISCV) products, published on 22 Aug 2018. It can only be exploited from the same machine or local network, with no action from the victim.
Exploitation: There is no known exploitation of CVE-2018-14787 in the wild and no public exploit code.

Affected product: Philips IntelliSpace Cardiovascular (ISCV) products. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2018-14787/ (Markdown: https://insights.sbomify.com/CVE-2018-14787/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2018-14787
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2018-14787
- OSV: https://osv.dev/vulnerability/CVE-2018-14787

---
From sbomify Insights: https://insights.sbomify.com/CVE-2018-14787/
Summaries are generated and may contain mistakes; the official description above is the record.